Last reviewed 2026-05-19 · How we verify

Pitavastin 4mg

University of Kansas Medical Center · FDA-approved active Small molecule ✓ Verified May 2026 Quality 13/100

Pitavastin 4mg is a Statins Small molecule drug developed by University of Kansas Medical Center. It is currently FDA-approved. Also known as: Livalo.

Pitavastatin 4mg is used to treat hypercholesterolemia, a condition characterized by high levels of cholesterol in the blood. It works by inhibiting HMG-CoA reductase, an enzyme involved in cholesterol production, as indicated by its classification in ChEMBL.

At a glance

Generic name	Pitavastin 4mg
Also known as	Livalo
Sponsor	University of Kansas Medical Center
Drug class	Statins
Target	HMG-CoA reductase
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

No approved indications tracked.

Pipeline indications

Common side effects

No common side effects on file.

Drug interactions

Cyclosporine
Gemfibrozil
Erythromycin
Itraconazole

Key clinical trials

A Study Comparing CoQ10 Levels While Taking 3 Different Statins (PHASE4)

Patents

Patent	Expiry	Type
US12345678

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results
FDA Orange Book	Patents + exclusivity

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Pitavastin 4mg CI brief — competitive landscape report
Pitavastin 4mg updates RSS · CI watch RSS
University of Kansas Medical Center portfolio CI

Frequently asked questions about Pitavastin 4mg

What is Pitavastin 4mg?

Pitavastin 4mg is a Statins drug developed by University of Kansas Medical Center.

Who makes Pitavastin 4mg?

Pitavastin 4mg is developed and marketed by University of Kansas Medical Center (see full University of Kansas Medical Center pipeline at /company/university-of-kansas-medical-center).

Is Pitavastin 4mg also known as anything else?

Pitavastin 4mg is also known as Livalo.

What drug class is Pitavastin 4mg in?

Pitavastin 4mg belongs to the Statins class. See all Statins drugs at /class/statins.

What development phase is Pitavastin 4mg in?

Pitavastin 4mg is FDA-approved (marketed).

What does Pitavastin 4mg target?

Pitavastin 4mg targets HMG-CoA reductase and is a Statins.

Drug class: All Statins drugs
Target: All drugs targeting HMG-CoA reductase
Manufacturer: University of Kansas Medical Center — full pipeline
Therapeutic area: All drugs in Metabolic
Also known as: Livalo

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing